Clinical Study of Combination Treatment of Recurrent Vulvovaginal Candidiasis of 48 Cases
Luo Zhen
Abstract
Luo Zhen
Abstract
Objective:To investigate the appropriate and therapy of treating recurrent vulvovaginal candidiasis(RVVC).Methods:Individual consolidated and maintenance therapy duration.Drugs were usded orally and vaginally together to consolidate the therapy.Oral drugs were itroconazole(200 mg,qn for 5days) or fluconazole(0.15 for one time or 0.15 qw after 0.15 q3d for 2 times).Nystatin(400 000 unit qn for 7 days)or Gyno-Daktarin(0.2 qn for 7 days)was vaginally used.Results:①Among 69 cases of RVVC,C.albicans was mostly detected(85.41%);②The effective rate of individual strengthening and solid therapy was 93.75%,the remote cure rate after discontinuing for 3 months,6 months and 12 months was respectively 89.58%,87.5% and 83.34%,respectively.Conclusions:The predominant pathogen in RVVC is C.albicans.The effective measures to cure RVVC are to Oral therapy and vagina therapy.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective:To investigate the appropriate and therapy of treating recurrent vulvovaginal candidiasis(RVVC).Methods:Individual consolidated and maintenance therapy duration.Drugs were usded orally and vaginally together to consolidate the therapy.Oral drugs were itroconazole(200 mg,qn for 5days) or fluconazole(0.15 for one time or 0.15 qw after 0.15 q3d for 2 times).Nystatin(400 000 unit qn for 7 days)or Gyno-Daktarin(0.2 qn for 7 days)was vaginally used.Results:①Among 69 cases of RVVC,C.albicans was mostly detected(85.41%);②The effective rate of individual strengthening and solid therapy was 93.75%,the remote cure rate after discontinuing for 3 months,6 months and 12 months was respectively 89.58%,87.5% and 83.34%,respectively.Conclusions:The predominant pathogen in RVVC is C.albicans.The effective measures to cure RVVC are to Oral therapy and vagina therapy.
Key concepts: Medicine, Vulvovaginal Candidiasis, Fluconazole, Nystatin, Cure rate, Candida albicans, Combination therapy, Vagina